Experimental vaccine shows promise in delaying the return of aggressive brain tumor
An experimental brain tumor vaccine targets a protein found in tumors called survivin
Source: dunyanews.tv
Stay updated with breaking news from John Wishman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An experimental brain tumor vaccine targets a protein found in tumors called survivin
A vaccine to slow the progression of the deadliest form of brain cancer has shown promise in early clinical trials by extending the average survival time from 15 to 26 months.
John Wishman was diagnosed with the deadliest form of brain cancer, glioblastoma, in fall 2020.